CLYM
Climb Bio, Inc. Common Stock
stockNASDAQ
Market OpenOct 5, 2026 11:47:54 AM EDT
10.92USD-0.183%(-0.02)382,905
10.90Bid10.92Ask0.02SpreadPre-marketOct 5, 2026 9:10:30 AM EDT
10.95USD+0.091%(+0.01)
CLYM News
Climb Bio to present Phase 2 data on kidney disease therapies · 
Investing.com
The Biggest Losers In Biotech — And It Had Nothing To Do With 'Compelling,' 'Best-In-Disease' Data · 
Investor's Business Daily